Walnut Creek, CA, United States of America

Savithri Ramurthy

USPTO Granted Patents = 37 (Patent Applications = 4)

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 11 (Patent Applications = 6)

Average Co-Inventor Count = 7.4

ph-index = 13

Forward Citations = 396(Granted Patents)

Location History:

Emeryville, CA (US) (2009 - 2019)
Arlington, MA (US) (2017 - 2019)
Cambridge, MA (US) (2017 - 2019)
Walnut Creek, CA (US) (2002 - 2020)

Company Filing History:

Novartis Vaccines & Diagnostics, Gmbh

Years Active: 2002-2020

Loading Chart...

37 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10709712 - Biaryl amide compounds as kinase inhibitors (2020-07-14),

2. 10392404 - Compounds and compositions as kinase inhibitors (2019-08-27),

3. 10377770 - Tricyclic compounds and compositions as kinase inhibitors (2019-08-13),

4. 10245267 - Biaryl amide compounds as kinase inhibitors (2019-04-02),

5. 10167279 - Compounds and compositions as RAF kinase inhibitors (2019-01-01),

6. 9809610 - Compounds and compositions as kinase inhibitors (2017-11-07),

7. 9694016 - Biaryl amide compounds as kinase inhibitors (2017-07-04),

8. 9573969 - Compounds and compositions as kinase inhibitors (2017-02-21),

9. 9546173 - Substituted pyrrolo[3,4-d]pyrimidines as kinase inhibitors (2017-01-17),

10. 9242969 - Biaryl amide compounds as kinase inhibitors (2016-01-26),

11. 8735599 - Substituted imidazole derivates (2014-05-27),

12. 8710048 - 6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling (2014-04-29),

13. 8614330 - Substituted benz-azoles and methods of their use as inhibitors of RAF kinase (2013-12-24),

14. 8592459 - Substituted benzimidazoles and methods of their use (2013-11-26),

15. 8415382 - Substituted benzazoles and methods of their use as inhibitors of RAF Kinase (2013-04-09),

Title: Savithri Ramurthy: Pioneering Innovations in Biaryl Amide Compounds

Introduction:

Savithri Ramurthy, a prolific inventor based in Walnut Creek, CA, has made significant contributions to the field of pharmaceuticals with a remarkable total of 37 patents to his name. His groundbreaking work focuses on developing novel compounds as kinase inhibitors for the treatment of disorders associated with Raf kinase activity.

Latest Patents:

Ramurthy's recent patents showcase his expertise in developing Biaryl amide compounds as kinase inhibitors. These compounds, represented by Formula (I) and (II), demonstrate potent therapeutic uses in tackling critical disorders linked to Raf kinase activity. The pharmaceutical compositions comprising these compounds offer promising avenues for improved treatments and potential cures.

Career Highlights:

Having worked at renowned companies such as Novartis AG and Novartis Vaccines & Diagnostics, GmbH, Ramurthy has gained extensive experience in the pharmaceutical industry. His visionary approach to drug discovery has led to the successful filing of numerous patents, highlighting his dedication to pushing the boundaries of medical innovation.

Collaborations:

Throughout his career, Ramurthy has collaborated with esteemed professionals in the field, including coworkers such as Sharadha Subramanian and Paul A Renhowe. These collaborations have not only enriched his own research but have also fostered a culture of innovation and knowledge-sharing within the organizations he has been a part of.

Conclusion:

In conclusion, Savithri Ramurthy's remarkable journey as an inventor showcases his unwavering commitment to advancing the field of pharmaceuticals through pioneering innovations in kinase inhibitor compounds. His extensive patent portfolio and collaborations underscore his pivotal role in shaping the future of medical treatments, making him a true trailblazer in the realm of drug discovery.

This text is generated by artificial intelligence and may not be accurate.